Technical Report 2012-2: Digoxin and Digitoxin Convert Atrial Fibrillation and Flutter to Regular Sinus Rhythm with Pharmacokinetically Optimized Dosage Regimens
Technical Report 2011-2: Some Comments and Suggestions concerning Population Pharmacokinetic Modeling, especially of Digoxin, Monitoring its Therapy with Serum Concentrations, and Optimizing its Clinical Dosage Regimens
Technical Report 2011-1: A Hybrid Bayesian method to obtain Bayesian Posterior Parameter Distributions in Nonparametric Pharmacokinetic Models for Individual Patients
Technical Report 2009-1: Human Genetic Variation, Population Pharmacokinetic – Dynamic Models, Bayesian Feedback Control, and Maximally Precise Individualized Drug Dosage Regimens